Kumari Minu, Rastogi Neha, Malhotra Rajesh, Mathur Purva
Division of Trauma Surgery and Critical Care, JPNATC, AIIMS, New Delhi, India.
Department of Laboratory Medicine, JPNATC, AIIMS, New Delhi, India.
J Lab Physicians. 2018 Oct-Dec;10(4):406-409. doi: 10.4103/JLP.JLP_85_18.
Device-associated infections constitute the majority of health-care infections in Intensive Care Units (ICUs). Trauma patients are more prone to acquire such infections; ventilator-associated pneumonia (VAP) being the most common Health care associated infections (HAI) in ICU has serious implications such as increased morbidity, prolonged hospital stay, and mortality. This study aims to compare the clinicomicrobiological profile of VAP and non-VAP trauma patients at Level I trauma center.
A 4-year retrospective study of prospectively maintained database was conducted at Level 1 trauma center from January 2013 to December 2016. The patients were classified into two groups named VAP and non-VAP patients. VAP patients were defined according to the criteria of the Centers for Disease Control and Prevention. The data were compiled and analyzed. Statistical data were analyzed using SPSS version 21 software.
During the study period, 134 (13%) cases of VAP and 909 (87%) non-VAP cases were observed in our study. The total number of ventilator days for VAP patients was 5128 days, which ranged from 2 to 82 days (median 42 days). The length of hospital stay in non-VAP category ranged from 1 to 390 days (median 195.5 days). Inhospital mortality was observed in 62 (46%) patients with VAP. Three hundred and eighteen (35%) non-VAP patients had also had a fatal outcome. Gram-negative organisms, most commonly spp. (13, 21%), were reported in the fatal VAP patients.
Higher rate of mortality was observed in patients with VAP in comparison to non-VAP patients, both being on mechanical ventilation. Early recognition of VAP, implementation of proper VAP preventive bundle strategies, and stringent infection control practices are essential mandates to prevent VAP.
在重症监护病房(ICU)中,与设备相关的感染占医疗保健感染的大多数。创伤患者更容易发生此类感染;呼吸机相关性肺炎(VAP)是ICU中最常见的医疗保健相关感染(HAI),具有严重的影响,如发病率增加、住院时间延长和死亡率上升。本研究旨在比较一级创伤中心VAP和非VAP创伤患者的临床微生物学特征。
2013年1月至2016年12月在一级创伤中心对前瞻性维护的数据库进行了为期4年的回顾性研究。患者分为VAP组和非VAP组。VAP患者根据疾病控制与预防中心的标准进行定义。对数据进行整理和分析。使用SPSS 21版软件对统计数据进行分析。
在研究期间,我们的研究中观察到134例(13%)VAP病例和909例(87%)非VAP病例。VAP患者的呼吸机使用天数总计为5128天,范围为2至82天(中位数42天)。非VAP组的住院时间为1至390天(中位数195.5天)。62例(46%)VAP患者发生了院内死亡。318例(35%)非VAP患者也有致命结局。在致命的VAP患者中报告了革兰氏阴性菌,最常见的是 菌属(13例,21%)。
与非VAP患者相比,VAP患者的死亡率更高,两者均接受机械通气。早期识别VAP、实施适当的VAP预防捆绑策略以及严格的感染控制措施是预防VAP的必要要求。